Chidamide with Azacitidine and CHOP Treatment Plus Autologous Transplantation,Followed By Maintenance with Chidamide for Patients with Newly Diagnosed Peripheral T-Cell Lymphoma: Interim Analysis of a Prospective,Single Center,Single-Arm, Phase 2 Trial

被引：0
|
作者：
Xiao, Chunyan [1 ]
Ding, Yao [1 ]
Zeng, Chensi [1 ]
Zhang, Lingqian [1 ]
Guo, Bingling [1 ]
Nan, Yingyu [1 ]
Liu, Yao [1 ]
机构：
[1] Chongqing Univ, Canc Hosp, Dept Hematol Oncol, Chongqing, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-181337
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Chidamide with Azacitidine and CHOP Treatment Plus Autologous Transplantation, Followed By Maintenance with Chidamide for Patients with Newly Diagnosed Peripheral T-Cell Lymphoma (PTCL): Interim Analysis of a Prospective,Single Center, Single-Arm, Phase 2 Trial
    Xiao, Chunyan
    Ding, Yao
    Zeng, Chensi
    Zhang, Lingqian
    Guo, Bingling
    Nan, Yingyu
    Liu, Yao
    BLOOD, 2022, 140 : 12010 - 12010
  • [2] Clinical trial: Chidamide plus CHOP improve the survival of newly diagnosed angioimmunoblastic T-cell lymphoma
    Zong, Xiangping
    Yang, Zhen
    Zhou, Jin
    Jin, Zhengming
    Wu, Depei
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [3] A Multicenter, Phase III Study of Chidamide, Azacitidine Combined with CHOP Versus CHOP in Patients with Untreated Peripheral T-Cell Lymphoma
    Wei, Chong
    Zhang, Yan
    Li, Jian
    Zhang, Wei
    Zhou, Daobin
    BLOOD, 2022, 140 : 6567 - 6568
  • [4] y Combination of Chidamide with the CHOEP Regimen in Previously Untreated Patients with Peripheral T-Cell Lymphoma (PTCL): A Prospective, Multicenter, Single-Arm, Phase 1b/2 Trial
    Zhang, Wei
    Su, Liping
    Liu, Lihong
    Gao, Yuhuan
    Wang, Quanshun
    Su, Hang
    Song, Yuqin
    Zhang, Huilai
    Shen, Jing
    Jing, Hongmei
    Wang, Shuye
    Cen, Xinan
    Liu, Hui
    Liu, Aichun
    Li, Zengjun
    Luo, Jianmin
    He, Jianxia
    Wang, Jingwen
    O'Connor, Owen A.
    Zhou, Daobin
    BLOOD, 2019, 134
  • [5] Chidamide As Maintenance in Peripheral T-Cell Lymphoma for Patients in Response after Induction Therapy: A Single Center Retrospective Study
    Zhu, Yanan
    Wei, Juying
    Yang, Chunmei
    Xie, Wanzhuo
    Tong, Yanhong
    Yu, Wen-Juan
    Jin, Jie
    BLOOD, 2023, 142
  • [6] Chidamide Maintenance Therapy after Induction or Salvage Treatment in Patients with Peripheral T-Cell Lymphoma Ineligible for Autologous Stem Cell Transplantation
    Guo, Wei
    Zhao, Yangzhi
    Wang, Xingtong
    Li, Jia
    Guo, Qiang
    Li, Junna
    Young, Ken H.
    Bai, Ou
    BLOOD, 2021, 138
  • [7] A Single-Center Retrospective Clinical Study of Chidamide in the Treatment of Adult Peripheral T-Cell Lymphoma
    Hu, Maogui
    Ding, Kaiyang
    Wang, Dongyao
    Wang, Xinchen
    Zhu, Xiaoyu
    BLOOD, 2021, 138
  • [8] Safety and Efficacy of Azacitidine and Chidamide Maintenance after Allogeneic Hematopoietic Stem Cell Transplantation for Patients with High-Risk Acute Myeloid Leukemia: Interim Analysis of a Prospective, Multicenter, Single-Arm, Phase II Clinical Trial
    Yang, Chuting
    Zheng, Yaling
    Song, Chaoyang
    Wu, Ming
    Wang, Lei
    Zhou, Xuan
    Yue, Chunyan
    Lin, Xiaonan
    Chen, Jie
    Zeng, Hui
    Huang, Rui
    Li, Yuhua
    BLOOD, 2023, 142
  • [9] Chidamide plus R-GDP for relapsed/refractory diffuse large B-cell lymphoma in patients ineligible for autologous transplantation: A prospective, single-arm, phase II study
    Chen, Guang-Liang
    Xue, Kai
    Zhang, Qunling
    Xia, Zu-guang
    Jin, Jia
    Li, Ran
    Liu, Yizhen
    Lv, Fangfang
    Hong, Xiaonan
    Li, Xiaoqiu
    Cao, Junning
    CANCER MEDICINE, 2024, 13 (16):
  • [10] A Phase II Study of Chidamide Plus R-CHOP in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma: An Interim Analysis
    Xu, Pengpeng
    Zhang, Muchen
    Fang, Ying
    Wang, Li
    Cheng, Shu
    Zhao, Wei-li
    BLOOD, 2017, 130
12345